MedTrace Logo

The Therapeutic Efficacy of Neurofeedback in Depression

NCT00729547 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2008-08-07

No results posted yet for this study

Summary

The investigators examined the therapeutic efficacy of neurofeedback in depression subjects. The investigators hypothesize that 5 weeks neurofeedback training will be able to alleviate depressive symptoms.

Conditions

Interventions

BEHAVIORAL

Neurofeedback

enhance relative activity level of left frontal activity

BEHAVIORAL

Psychotherapy placebo

These sessions consisted of additional assessment, interpretation of the test results and providing information on course and treatment of mood disorder.

Sponsors & Collaborators

  • Korea Research Foundation

    collaborator OTHER

  • Kyunghee University

    collaborator OTHER

  • Korea University

    lead OTHER

Principal Investigators

  • Hyuntaek Kim, PHD · Department of Psychology, Korea university

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
FACTORIAL

Eligibility

Min Age
20 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-09-30
Primary Completion
2006-12-31
Completion
2007-01-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00729547 on ClinicalTrials.gov